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Purpose: In order to improve the likelihood of curative and
safe gastric surgery, this study investigated the clinical
features and surgical outcomes of gastric cancer with a
synchronous cancer. Patients and Methods: The clinico-
pathological data of 10,090 gastric cancer patients at Samsung
Medical Center from September 1994 to December 2006 were
retrospectively analyzed. Of them, 90 patients with gastric
cancer and a synchronous second primary cancer underwent
simultaneous surgery for gastric cancer and second primary
cancer. The clinicopathological characteristics of the patients,
surgical outcome, and prognosis were examined. Results: The
most common synchronous second primary cancer was
colorectal cancer (37 patients), followed by hepatocellular
carcinoma (13 patients), renal cell carcinoma (11 patients),
and pancreatic carcinoma (5 patients). The incidence of a
second primary cancer in the gastric cancer patients was
higher than the incidence in the general population. Stage I
gastric cancer patients had more synchronous cancers than
stage II patients (59 vs. 31). Postoperative complications were
encountered in 7 patients. Four patients underwent reopera-
tion. Two patients died from hepatic failure and leakage of
esophagojejunal anastomosis. The 5-year survival rate of stage
I and II gastric cancer was 61% and 39%, respectively.
Conclusion: Since gastric cancer patients with a synchronous
second primary cancer are not rare, the possibility of
synchronous cancers in gastric cancer patients should be
considered. The prognosis of early stage gastric cancer
patients with a synchronous second primary cancer was
influenced more by the presence of the second primary cancer
than by the gastric cancer itself.
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INTRODUCTION
Although the number of cancer deaths has
declined, gastric cancer is the one of the most
common causes of cancer death in Korea.
1
Recently, the prognosis of gastric cancer has
improved due to early diagnosis, enhancement
of surgical techniques, and the development of
new chemotherapeutic agents,
2-5 but gastric
cancer remains the second most common cause
of death in Korea. The incidence of gastric
cancer with a second primary cancer is growing
along with the increasing age of gastric cancer
patients.
6 The prognosis of early gastric cancer is
excellent, and it can be treated with curative
resection if another incurable cancer is not
present. A second primary cancer may influence
the prognosis of gastric cancer, making it
important to recognize the clinicopathological
characteristics and outcome of gastric cancer
with a synchronous second primary cancer.
6-8
There are no reports of the surgical results of
combined surgery for gastric cancer and a
synchronous second primary cancer. Moreover,
there are only a few discussions of the features
related to gastric cancer with a synchronous and
metachronous second primary cancer.
6-12 The
best simultaneous treatment for gastric cancer
with a synchronous second primary cancer has
not been determined definitively. This study
examined the clinicopathological significance,
surgical outcome, and prognosis of gastric
cancer patients with a synchronous second
primary cancer who underwent a simultaneous
surgical resection.
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PATIENTS AND METHODS
This study retrospectively analyzed 10,090
patients who underwent gastric surgery for
gastric cancer at the Department of Surgery,
Samsung Medical Center, from September 1994 to
December 2006. Among the 10,090 patients, we
analyzed those who had undergone a gastrectomy
and combined surgery for a synchronous second
primary cancer. Synchronous second primary
cancers were defined as cancer diagnosed in
organs other than the stomach, at the same time
or within six months before the diagnosis of the
first primary cancer. In total, 96 patients were
identified with gastric cancer and a synchronous
second primary cancer. Abdominopelvic computed
tomography, esophagogastroduodenoscopy, and
double contrast barium study were performed
routinely before the operation. Six patients could
not undergo a gastrectomy because of the unre-
sectability of the cancer. Ninety gastrectomies and
surgeries on the second primary cancer were
performed within one month of diagnosis. The
synchronous second primary cancers were con-
firmed pathologically by surgery or a preoperative
biopsy. Clinicopathological characteristics in-
cluding age, gender, operation, histology, stage,
and complications were reviewed.
Statistical analysis
The data were analyzed using the Statistical
Package for Social Science (SPSS) version 12.0 for
Windows (SPSS, Inc, Chicago, IL). The survival
curve was calculated using the Kaplan-Meier
procedure. A p value < 0.05 was considered
significant.
RESULTS
Clinicopathological features of all gastric cancer
patients
Among the 10,090 gastric cancer patients, 96
(1.0%) had a synchronous cancer on the other
organs. Of these 96 patients, 6 could not undergo
a gastrectomy due to the unresectability of their
cancer. Overall, 90 patients underwent a gastrec-
tomy combined with surgery for a synchronous
second primary cancer. Table 1 shows their
clinicopathological characteristics. Of the 90
patients, 75 were male (83.3%) and 47 (52.2%) had
early gastric cancer. Stage I gastric cancer (59
patients, 65.6%) was the most common stage
(Table 1).
Site and incidence of synchronous second primary
cancer
The most common site of the second primary
cancer was the colorectum, followed by the liver,
kidney, and pancreas. Fig. 1 shows the incidence
of the second primary cancer in gastric cancer
patients who underwent gastrectomy at our
hospital along with the incidence of cancer in the
general population in Korea for comparison
13.
Patients with gastric cancer had a higher incidence
of colorectum, liver, kidney, and pancreas cancer.
Colorectal cancer was the most commonSecond Primary Cancer in Patients with Gastric Cancer
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synchronous cancer in gastric cancer. While other
studies
6,7 reported lung cancer to be most common,
followed by colorectal cancer, hepatocellular
carcinoma was the second most common cancer in
this study. During the follow-up period, a newly
developed cancer was identified in three patients.
One patient, who had colon cancer, previously
underwent a pancreaticoduodenectomy for duo-
denal cancer followed by left hemicolectomy. The
other patient, who underwent a right hemicolec-
tomy due to an ascending colon cancer, was
diagnosed with renal cell carcinoma, but could
not undergo surgery because the tumor was
unresectable. The final patient, who was diagnosed
with ascending colon cancer, had bladder cancer
and underwent a transurethral resection of the
bladder.
Surgery for the synchronous second primary cancer
Table 2 shows the gastric surgical procedures
for the combined gastric cancer and synchronous
second primary cancer. All patients underwent
gastric cancer surgery. A distal gastrectomy (58,
64.4%) was most common, followed by a total
gastrectomy (28, 31.1%), pancreaticoduodenec-
tomy (2, 2.2%), proximal gastrectomy (1, 1.1%), and
a local excision (1, 1.1%). Postoperative complica-
Table 1. Clinicopathologic Characteristics of Patients with Gastric Cancer with and without Synchronous
Second Primary Cancer
Factors
Gastric cancer with SPC
n = 90 (%)
Gastric cancer without SPC
n = 10,000 (%)
Sex
Male 75 (83.3) 6,625 (66.3)
Female 15 (16.7) 3,375 (33.8)
Age (yrs) 60.8 ± 10.3 55.6 ± 12.0
Depth of invasion
T1 (EGC) 47 (52.2) 4,539 (45.4)
T2 - 4 (AGC) 43 (47.8) 5,026 (50.2)
Unknown 0 (0.0) 435 (4.4)
Differentiation
Differentiated 56 (62.2) 4,350 (43.5)
Undifferentiated 33 (36.7) 5,404 (54.0)
Others 1 (1.1) 37 (0.4)
Unknown 0 (0.0) 209 (2.1)
Stage
I 59 (65.6) 4,785 (47.9)
II 12 (13.3) 1,151 (11.5)
III 12 (13.3) 1,069 (10.7)
IV 7 (7.8) 1,736 (17.4)
Unknown 0 (0.0) 1,259 (12.6)
Curability
R0 88 (97.8) 8,860 (88.6)
R1 2 (2.2) 449 (4.5)
R2 0 (0.0) 691 (6.9)
EGC, early gastric cancer; AGC, advanced gastric cancer; SPC, second primary cancer; Others, hepatoid adenocarcinoma,
adenosquamous carcinoma, anaplastic carcinoma, lymphoepithelioma like carcinoma, small cell carcinoma, composite
adenocarcinoma-neuroendocrine carcinoma.Tae Kyung Ha, et al.
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tions were encountered in seven patients in-
cluding hepatic failure (2 patients), pneumonia
(1 patient), wound dehiscence (1 patient), subphrenic
abscess (1 patient), leakage of anastomosis
(1 patient), and mechanical ileus (1 patient). The
patient with hepatic failure underwent a shunt
operation to control the ascites and survived. Two
patients died of hepatic failure and leakage
caused by esophagojejunal anastomosis.
Site distribution of the second primary cancer and
5-year survival rate
Table 3 shows the site distribution of second
primary cancers in patients with gastric cancer,
the number of dead patients, and the 5-year
survival rate according to the stage of gastric
cancer. The 5-year survival rates of stage I and II
gastric cancer were 61% and 39%, respectively,
which are less than that of patients with gastric
cancer without a second primary cancer.
14 The
5-year survival rate of patients with colorectal
cancer and a gastric cancer was 66%, which is
higher than that of patients with other cancers.
However all patients with pancreas cancer and
gastric cancer died. The synchronous second
primary cancer adversely affected the survival of
early stage gastric cancer patients.
Table 2. Classification of Gastric Cancer Operations and Combined Operations for Synchronous Second Primary
Cancer
Total
gastrectomy
Distal
gastrectomy
Proximal
gastrectomy Others
Colorectum Anterior resection 1 3 0 0
Hartmann’s operation 0 4 0 0
Low anterior resection 4 3 1 0
Miles’ operation 0 1 0 0
Right hemicolectomy 1 14 0 0
TEM 1 1 0 0
Total colectomy 1 0 0 1
Liver Enucleation 1 2 0 0
Intraoperative radiofrequency ablation 2 1 0 0
Lobectomy 3 2 0 0
Sectionectomy 1 3 0 0
Gallbladder,
Pancreas
Cholecystectomy 1 2 0 0
Pancreaticoduodenectomy 1 3 0 2
Distal pancreatectomy 1 1 0 0
Kidney Radical nephrectomy 4 7 0 0
Breast Breast conservation surgery 1 0 0 0
Thyroid Total thyroidectomy 0 3 0 0
Lung Lobectomy 0 3 0 0
Esophagus Esophagectomy 3 0 0 0
Prostate TURP 0 1 0 0
Ureter Nephroureterectomy 0 1 0 0
Neck Radical neck dissection 1 0 0 0
Melanoma SNB & wide excision 0 1 0 0
Cervix TAH & BSO 0 1 0 0
Others, local excision, pancreaticoduodenectomy; TEM, transanal endoscopic microsurgery; TURP, transurethral resection of
the prostate; SNB, sentinel node biopsy; TAH & BSO, total abdominal hysterectomies with bilateral salpingo-oophrectomy.Second Primary Cancer in Patients with Gastric Cancer
Yonsei Med J Vol. 48, No. 6, 2007
DISCUSSION
The incidence of gastric cancer with a
synchronous second primary cancer varies from
2.0% to 10.9%.
6-8 Our incidence (1.0%) was lower
than that of other reports. However, this lower
incidence might be due to the fact that this study
analyzed patients who had undergone a gastrectomy
and combined surgery for a synchronous second
primary cancer and examined the prognosis of
these patients.
The detection of early gastric cancer is better
due to the aid of radiologic diagnostic tools, mass
screening, interest in health, and increasing patient
age.
2,4 Therefore, there has been an increase in the
rate of detection of synchronous second primary
cancers. The prognosis of early gastric cancer is
more favorable than advanced gastric cancer, but
there are few reports on how to treat or improve
the survival of patients with a synchronous
second primary cancer,
6-12 which remains a key
challenge.
Colorectal cancer is diagnosed most commonly
in patients with gastric cancer.
6-9,12 We found that
colorectal cancer was the most common synchron-
ous cancer in gastric cancer. The incidence of
colorectal cancer is increasing rapidly in Korea,
1
which might affect the detection of a synchronous
colon cancer. Lung cancer was also quite prevalent.
However, we encountered only three lung cancer
patients because only synchronous second primary
cancers were investigated and lung cancer is
usually detected metachronously.
7 Colorectal and
gastric cancer might be closely related, and there
are data to support this relationship. Gastric
cancer is the most common extra-colonic cancer
associated with hereditary non-polyposis colorectal
cancer (HNPCC) syndrome.
15 Familial gastric cancer
is independently associated with the presence of
a synchronous colorectal cancer. In addition, a
mismatch repair gene has been identified in
gastric cancer as well as in colorectal cancer.
16,17
However, the basic mechanism for carcinogenesis
is unknown. In this report, the survival of patients
with colorectal cancer and gastric cancer was
higher than that of the other cancers.
Hepatocellular carcinoma (HCC) is a very com-
mon malignancy in Korea,
1 but the co-existence
of HCC and gastric cancer is rare.
18 A differential
diagnosis of primary HCC should be made
because the liver is a metastatic site of gastric
cancer. Therefore, a definitive management
strategy for synchronous HCC and gastric cancer
has not been established. Some studies have
reported that synchronous cancer, including
gastric cancer, has no effect on postoperative
survival in patients with HCC when a simulta-
neous resection is performed.
18,19 Although a
combined resection might be possible, the
surgical options are more restricted than those
for other malignancies because HCC patients also
have liver cirrhosis and limited liver function.
20
We encountered five early gastric cancer cases
and eight advanced gastric cancer cases with
HCC. Only one patient with early gastric cancer
who underwent a subtotal gastrectomy and
Table 3. Site Distribution of Synchronous Second Primary Cancers in Patients with Gastric Cancer and 5-Year
Survival Rate
Site
Stage of gastric cancer
I II III IV 5 YSR (%)
Colorectum 27 (5) 2 (0) 5 (2) 3 (2) 66
Liver 7 (4) 3 (3) 2 (1) 1 (1) 43
Kidney 6 (2) 3 (2) 1 (1) 1 (1) 24
Pancreas 4 (4) 1 (1) 0 (0) 0 (0) 0
Others 15 (4) 3 (1) 4 (2) 2 (1) 60
5 YSR (%) 61 39 30 0
Others: GB (1), bile duct (2), lung (3), appendix (1), mucoepidermoid tumor (1).
Parenthesis: number of patients who died.
YSR, year survival rate.Tae Kyung Ha, et al.
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sectionectomy of the liver died from postopera-
tive hepatic failure. Minimal invasive surgery
should be considered when gastric cancer is
identified as early stage in patients with HCC.
Since the risk of lymph node metastasis is low, a
lymph node dissection is not performed routinely,
which later causes massive lymphorrhea, posto-
perative morbidity, and death.
21 The most com-
mon cause of death in patients with HCC and
gastric cancer is the recurrence of HCC.
18,19
The incidence of gastric cancer with renal cell
carcinoma is quite low.
22,23 Moreover, synchronous
surgery of gastric cancer and renal cell carcinoma
is extremely rare.
6,7 On the other hand, patients
with renal cell carcinoma have a significantly
higher risk of other subsequent primary malign-
ancies.
6,7,24 A curative resection was performed on
11 patients diagnosed with gastric cancer com-
bined with renal cell carcinoma in this study. One
of them died from postoperative morbidity
because of anastomosis leakage. During the post-
operative follow-up period, renal cell carcinoma
and gastric cancers recurred in six patients, five of
whom died.
The incidence of a second primary gastric
cancer is increasing more in males than females,
and tends to be higher in elderly patients.
6,7 The
incidence of synchronous cancer in early stage
gastric cancer is higher than that in advanced
stage
25. This finding is associated with a trend in
recent gastric cancer epidemiology and the
features of gastric cancer in Korea.
The prognosis of gastric cancer is not as good
as expected. However, the prognosis of early
gastric cancer has been improved.
14 In this study,
the 5-year survival rate of stage I and II gastric
cancer was 61% and 39%, respectively. Therefore,
the presence of the second primary cancer has a
more adverse effect on the prognosis of early
stage gastric cancer with a synchronous second
primary cancer than the gastric cancer itself.
In conclusion, the incidence of early gastric
cancer has increased recently. Surgeons need to be
aware of the possibility of a synchronous second
primary cancer with gastric cancer because the
prognosis of early gastric cancer is adversely
affected by the presence of a second primary
cancer.
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